Current and future approaches using genetically modified mice in endocrine research

被引:38
|
作者
Davey, Rachel A. [1 ]
MacLean, Helen E. [1 ]
机构
[1] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic 3084, Australia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2006年 / 291卷 / 03期
关键词
transgenic; knockout; knock-in; cre-loxp; functional genomics; physiology;
D O I
10.1152/ajpendo.00124.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetically modified mouse models have been used widely to advance our knowledge in the field of endocrinology and metabolism. A number of different approaches to generate genetically modified mice are now available, which provide the power to analyze the role of individual proteins in vivo. However, there are a number of points to be considered in the use and interpretation of these models. This review discusses the advantages and disadvantages involved in the generation and use of different genetically modified mouse models in endocrine research, including conventional techniques (e.g., overexpression, knockout, and knock- in models), tissue- and/or time-specific deletion of target genes [e.g., Cre-loxP and short interfering (si) RNA transgenic approaches], and gene-trap approaches to undertake functional genomics. This review also highlights the many factors that should be considered when assessing the phenotype of these mouse models, many of which are relevant to all murine physiological studies. These approaches are a powerful means by which to dissect the function of genes and are revolutionizing our understanding of endocrine physiology and metabolism.
引用
收藏
页码:E429 / E438
页数:10
相关论文
共 50 条
  • [1] The funny current in genetically modified mice
    DiFrancesco, Mattia L.
    Mesirca, Pietro
    Bidaud, Isabelle
    Isbrandt, Dirk
    Mangoni, Matteo E.
    PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY, 2021, 166 : 39 - 50
  • [2] Approaches for timeline reductions in pathogenesis studies using genetically modified mice
    Skavicus, Samantha
    Heaton, Nicholas S.
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [3] Approaches for timeline reductions in pathogenesis studies using genetically modified mice
    Skavicus, Samantha
    Heaton, Nicholas S.
    MICROBIOLOGY SPECTRUM, 2023,
  • [4] Genetically modified crops: current status and future prospects
    Krishan Kumar
    Geetika Gambhir
    Abhishek Dass
    Amit Kumar Tripathi
    Alla Singh
    Abhishek Kumar Jha
    Pranjal Yadava
    Mukesh Choudhary
    Sujay Rakshit
    Planta, 2020, 251
  • [5] Genetically modified crops: current status and future prospects
    Kumar, Krishan
    Gambhir, Geetika
    Dass, Abhishek
    Tripathi, Amit Kumar
    Singh, Alla
    Jha, Abhishek Kumar
    Yadava, Pranjal
    Choudhary, Mukesh
    Rakshit, Sujay
    PLANTA, 2020, 251 (04)
  • [6] Therapeutic approaches using genetically modified cells
    Anliker, Brigitte
    Renner, Matthias
    Schweizer, Matthias
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2015, 58 (11-12) : 1274 - 1280
  • [7] Genetically modified animals in pharmacological research:: future trends
    Rudolph, U
    Möhler, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 375 (1-3) : 327 - 337
  • [8] Of mice and molecules: Research with genetically modified mouse models
    Shostak, S
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2005, : 90 - 99
  • [9] VIRTUAL MODIFIED DELPHI RESEARCH INTO CURRENT AND FUTURE MANAGEMENT APPROACHES OF MULTIPLE MYELOMA IN SWEDEN
    Roberts, G.
    Mumford, J.
    Mumford, A.
    VALUE IN HEALTH, 2020, 23 : S461 - S461
  • [10] Genetically modified cancer vaccines: Current status and future prospects
    Hu, Xiaoyi
    Zhou, Weilin
    Pi, Ruyu
    Zhao, Xia
    Wang, Wei
    MEDICINAL RESEARCH REVIEWS, 2022, 42 (04) : 1492 - 1517